Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2017 2
2018 2
2023 5
2024 2
2025 1
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following terms were ignored: %, %
The following terms were not found in PubMed: 5BAuthor
Page 1
Showing results for saude e%5BAuthor%5D
Your search for Sarde E%5BAuthor%5D retrieved no results
Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study.
Lourenço-Silva N, Sousa-Pinto B, Bognanni A, Pereira AM, Coutinho-Almeida J, Amaral R, Brussino L, Giovannini M, Gemicioglu B, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Valiulis A, Vecillas LL, Ventura MT, Pfaar O, Fonseca JA, Zuberbier T, Klimek L, Bousquet J, Vieira RJ. Lourenço-Silva N, et al. Clin Exp Allergy. 2026 Aug;56(8):904-913. doi: 10.1111/cea.70335. Epub 2026 May 6. Clin Exp Allergy. 2026. PMID: 42087806 Free PMC article.
We compared rhinitis medication classes and individual medications on health utilities (computed from the EQ-5D-5L questionnaire) and the EQ-5D VAS. To account for confounding, we employed inverse probability treatment weighting based on propensity scores, adjusting …
We compared rhinitis medication classes and individual medications on health utilities (computed from the EQ-5D-5L questionnaire) and …
Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS).
Cury FL, Viani GA, Gouveia AG, Freire CVS, Grisi GA, Moraes FY. Cury FL, et al. Radiother Oncol. 2024 Jan;190:109935. doi: 10.1016/j.radonc.2023.109935. Epub 2023 Oct 25. Radiother Oncol. 2024. PMID: 37884194 Review.
Better local control and R0 margins were associated with regimens using higher BED, i.e., doses equal to or higher than 30 Gy when using 5 fractions....
Better local control and R0 margins were associated with regimens using higher BED, i.e., doses equal to or higher than 30 Gy when us …
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.
Bousquet J, Shamji MH, Anto JM, Schünemann HJ, Canonica GW, Jutel M, Del Giacco S, Zuberbier T, Pfaar O, Fonseca JA, Sousa-Pinto B, Klimek L, Czarlewski W, Bedbrook A, Amaral R, Ansotegui IJ, Bosnic-Anticevich S, Braido F, Chaves Loureiro C, Gemicioglu B, Haahtela T, Kulus M, Kuna P, Kupczyk M, Matricardi PM, Regateiro FS, Samolinski B, Sofiev M, Toppila-Salmi S, Valiulis A, Ventura MT, Barbara C, Bergmann KC, Bewick M, Blain H, Bonini M, Boulet LP, Bourret R, Brusselle G, Brussino L, Buhl R, Cardona V, Casale T, Cecchi L, Charpin D, Cherrez-Ojeda I, Chu DK, Cingi C, Costa EM, Cruz AA, Devillier P, Dramburg S, Fokkens WJ, Gotua M, Heffler E, Ispayeva Z, Ivancevich JC, Joos G, Kaidashev I, Kraxner H, Kvedariene V, Larenas-Linnemann DE, Laune D, Lourenço O, Louis R, Makela M, Makris M, Maurer M, Melén E, Micheli Y, Morais-Almeida M, Mullol J, Niedoszytko M, O'Hehir R, Okamoto Y, Olze H, Papadopoulos NG, Papi A, Patella V, Pétré B, Pham-Thi N, Puggioni F, Quirce S, Roche N, Rouadi PW, Sá-Sousa A, Sagara H, Sastre J, Scichilone N, Sheikh A, Sova M, Suppli Ulrik C, Taborda-Barata L, Todo-Bom A, Torres MJ, Tsiligianni I, Usmani OS, Valovirta E, Vasankari T, Vieira RJ, Wallace D, Waserma… See abstract for full author list ➔ Bousquet J, et al. Allergy. 2023 Jul;78(7):1758-1776. doi: 10.1111/all.15740. Allergy. 2023. PMID: 37042071 Free article. Review.
Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. T …
Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e …
Long-term Health-Related Quality of Life and Outcomes after Hospitalization for COVID-19 in Brazil: Post-COVID Brazil 1 Study Protocol.
Trott G, Scolari FL, Rover MM, Silva MMDD, Souza D, Santos RDRMD, Schardosim RFC, Rech GS, Mesquita Neto J, Estivalete GP, Freitas HJM, Itaqui CR, Kozesinski-Nakatani AC, Biolo A, Marcolino MS, Barreto BB, Schvartzman PR, Antonio ACP, Robinson CC, Falavigna M, Polanczyk CA, Rosa RG. Trott G, et al. Arq Bras Cardiol. 2023 Nov;120(11):e20230378. doi: 10.36660/abc.20230378. Arq Bras Cardiol. 2023. PMID: 37991122 Free PMC article. English, Portuguese.
The primary endpoint is defined as the health-related quality-of-life utility score assessed by the EuroQol-5D-3L (EQ-5D-3L) questionnaire at 12 months. Secondary endpoints are defined as the EQ-5D-3L at three, six and nine months, return to work or education …
The primary endpoint is defined as the health-related quality-of-life utility score assessed by the EuroQol-5D-3L (EQ-5D-3L) q …
Health-Related Quality of Life and Long-Term Outcomes after Mildly Symptomatic COVID-19: The Post-COVID Brazil Study 2 Protocol.
Rover MM, Trott G, Scolari FL, Silva MMDD, Souza D, Santos RDRMD, Dagnino APA, Mesquita Neto J, Estivalete GP, Kozesinski-Nakatani AC, Marcolino MS, Barreto BB, Schvartzman PR, Antonio ACP, Robinson CC, Falavigna M, Biolo A, Polanczyk CA, Rosa RG. Rover MM, et al. Arq Bras Cardiol. 2023 Sep;120(9):e20220835. doi: 10.36660/abc.20220835. Arq Bras Cardiol. 2023. PMID: 37851732 Free PMC article. English, Portuguese.
The primary outcome is the health-related quality-of-life utility score, assessed using the EuroQol-5D-3L (EQ-5D-3L) questionnaire at 12 months. Secondary endpoints include the EQ-5D-3L at 3, 6, and 9 months, as well as all-cause mortality, major cardiovascul …
The primary outcome is the health-related quality-of-life utility score, assessed using the EuroQol-5D-3L (EQ-5D-3L) questionn …
Further evidence on EQ-5D-5L preference inversion: a Brazil/U.S. collaboration.
Craig BM, Monteiro AL, Herdman M, Santos M. Craig BM, et al. Qual Life Res. 2017 Sep;26(9):2489-2496. doi: 10.1007/s11136-017-1591-8. Epub 2017 May 8. Qual Life Res. 2017. PMID: 28484914
Our aim was to confirm past findings of EQ-5D-5L preference inversions among English-speaking respondents and to explore inversions among Portuguese-speaking respondents. ...Starting today, 30 days with health problems: Severely anxious or depressed or Extremely anxious or …
Our aim was to confirm past findings of EQ-5D-5L preference inversions among English-speaking respondents and to explore inversions a …
Distinction between allergic rhinitis alone and allergic rhinitis + asthma in MASK-air® real-world studies; a ARIA-WAO task force review.
Sousa-Pinto B, Vieira RJ, Pereira AM, Togias A, Klimek L, Koppelman GH, Melén E, Papadopoulos NG, Al-Nesf MA, Brussino L, Cruz AA, Gemicioglu B, Kvedariene V, Larenas-Linnemann DE, Nadif R, Regateiro FS, Samolinski B, Savouré M, Taborda-Barata L, Toppila-Salmi SK, Ventura MT, Rouadi PW, Fiocchi A, Gomez MR, Wong GWK, Ansotegui IJ, Haahtela T, Anto JM, Zuberbier T, Fonseca JA, Morais-Almeida M, Bousquet J. Sousa-Pinto B, et al. World Allergy Organ J. 2026 Jul 31;19(8):101435. doi: 10.1016/j.waojou.2026.101435. eCollection 2026 Aug. World Allergy Organ J. 2026. PMID: 42571417 Free PMC article. Review.
(v) Patients with AR + A had different EQ-5D patterns than those with AR alone. (vi) Large differences were found between AR alone and AR + A in work impairment, resulting in higher weekly indirect costs in all OECD countries in AR + A by comparison to AR alone. ...
(v) Patients with AR + A had different EQ-5D patterns than those with AR alone. (vi) Large differences were found between AR alone an …
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study.
Sousa-Pinto B, Jácome C, Pereira AM, Regateiro FS, Almeida R, Czarlewski W, Kulus M, Shamji MH, Boulet LP, Bonini M, Brussino L, Canonica GW, Cruz AA, Gemicioglu B, Haahtela T, Kupczyk M, Kvedariene V, Larenas-Linnemann D, Louis R, Niedoszytko M, Pham-Thi N, Puggioni F, Romantowski J, Sastre J, Scichilone N, Taborda-Barata L, Ventura MT, Vieira RJ, Agache I, Bedbrook A, Bergmann KC, Amaral R, Azevedo LF, Bosnic-Anticevich S, Brusselle G, Buhl R, Cecchi L, Charpin D, Loureiro CC, de Blay F, Del Giacco S, Devillier P, Jassem E, Joos G, Jutel M, Klimek L, Kuna P, Laune D, Luna Pech J, Makela M, Morais-Almeida M, Nadif R, Neffen HE, Ohta K, Papadopoulos NG, Papi A, Pétré B, Pfaar O, Yeverino DR, Cordeiro CR, Roche N, Sá-Sousa A, Samolinski B, Sheikh A, Ulrik CS, Usmani OS, Valiulis A, Vandenplas O, Vieira-Marques P, Yorgancioglu A, Zuberbier T, Anto JM, Fonseca JA, Bousquet J. Sousa-Pinto B, et al. Lancet Digit Health. 2023 Apr;5(4):e227-e238. doi: 10.1016/S2589-7500(23)00020-1. Epub 2023 Mar 3. Lancet Digit Health. 2023. PMID: 36872189 Free article.
Using the Mobile Airways Sentinel Network for airway diseases (MASK-air) app, we developed and validated an electronic daily asthma control score (e-DASTHMA). METHODS: We used MASK-air data (freely available to users in 27 countries) to develop and assess different daily c …
Using the Mobile Airways Sentinel Network for airway diseases (MASK-air) app, we developed and validated an electronic daily asthma control …
Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®.
Bousquet J, Sousa-Pinto B, Anto JM, Bedbrook A, Czarlewski W, Ansotegui IJ, Bergmann KC, Braido F, Brussino L, Cecchi L, Loureiro CC, Cruz AA, Devillier P, Fiocchi A, Gemicioglu B, Haahtela T, Ivancevich JC, Klimek L, Kulus M, Kuna P, Kupczyk M, Kvedariene V, Larenas-Linnemann DE, Louis G, Louis R, Makris M, Morais-Almeida M, Niedoszytko M, Ohta K, Ollert M, Papadopoulos N, Patella V, Pétré B, Pfaar O, Puggioni F, Quirce S, Regateiro FS, Roche N, Rouadi PW, Samolinski B, Sastre J, Schleich F, Scichilone N, Taborda-Barata L, Toppila-Salmi S, Valiulis A, Vardaloglu Koyuncu I, Ventura MT, Yorgancioglu A, Fonseca JA, Zuberbier T. Bousquet J, et al. Clin Transl Allergy. 2024 Sep;14(9):e12390. doi: 10.1002/clt2.12390. Clin Transl Allergy. 2024. PMID: 39313483 Free PMC article.
VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness....
VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for all …
Health-related quality of life of patients of Brazilian primary health care.
Ascef BO, Haddad JPA, Álvares J, Guerra AA Junior, Costa EA, Acurcio FA, Guibu IA, Costa KS, Karnikowski MGO, Soeiro OM, Leite SN, Silveira MR. Ascef BO, et al. Rev Saude Publica. 2017 Nov 13;51(suppl 2):22s. doi: 10.11606/S1518-8787.2017051007134. Rev Saude Publica. 2017. PMID: 29160458 Free PMC article.
METHODS: This is a cross-sectional study with data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos - Servicos, 2015 (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines - Services, 2015). Data wer …
METHODS: This is a cross-sectional study with data from the Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de …
17 results